Axis 2 coordinator

Philippe LOISEAU
Chimiothérapie Antiparasitaire, Université Paris Sud

Jean-Daniel LELIEVRE
Physiopathologie du VIH, Immunologie clinique, APHP

Roger LEGRAND
Infections Virales, Maladies Auto-immunes, CEA

Evelyne JOUVIN-MARCHE
Immunologie, inflammation, infectiologie et microbiologie (I3M), INSERM

Françoise BOTTEREL-CHARTIER
Parasitologie, Mycologie - APHP


Supported projects : "AXIS 2: Prevent and treat infectious diseases"


DIM Axes

AXIS 1:
Anticipate the emergence of human and animal infectious diseases

  • Contribution of broad methodologies
  • Study of impacts on environmental impacts
  • Epidemiological surveillance

AXIS 2:
Prevent and treat infectious diseases

  • Innovative approaches to vaccination
  • New therapeutic strategies (human or animal)
  • Impact of genetic variability of hosts for their immune defenses against pathogens and responses to vaccination

AXIS 3:
Social Perceptions of Infectious Disease Prevention and Innovation

  • Impacts of therapeutic and diagnostic innovations
  • Transformations of relationships between humans and animals